Powered by

-EQUILLIUM STRENGTHENS LEADERSHIP TEAM WITH KEY APPOINTMENTS

Feb 28, 2020 - ENP Newswire
Board and Executive Moves

LA JOLLA - Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimmune and inflammatory disorders, today announced the appointment of Maple Fung, M.D., as vice president of clinical development and Matthew Ritter, Ph.D., as vice president of corporate development.

Dr. Fung will be responsible for leading Equillium's clinical development programs and integrating the Equillium's deve...